Jae Hyun Lee
Subscribe to Jae Hyun Lee's Posts
Jae Hyun Lee is a member of the Healthcare Practice Group. He focuses his practice on healthcare mergers and acquisitions as well as regulatory and compliance matters. Read Jae's full bio here.
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B
By Monica Wallace, Emily Jane Cook, Gregory E. Fosheim and Jae Hyun Lee on Apr 25, 2024
Posted In Life Sciences
On April 15, the Centers for Medicare & Medicaid Services (CMS) released a fact sheet on the potential national coverage determination (NCD) for pre-exposure prophylaxis (PrEP) using antiretroviral drugs to prevent HIV. CMS did not announce any coverage changes in the fact sheet but is providing advance information to avoid any possible disruptions to beneficiaries...
Continue Reading
This Week in 340B: February 21 – 26, 2024
By Emily Jane Cook, Reuben Bank, Bryan Frederick, Jae Hyun Lee, Patrick Moore and Kelsey Reinhardt on Feb 26, 2024
Posted In 340B
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of...
Continue Reading
HRSA Issues Notice Confirming 340B Registration Requirement
By Emily Jane Cook, Steven Schnelle and Jae Hyun Lee on Oct 27, 2023
Posted In 340B
On October 26, the Health Resources and Services Administration (HRSA) published a Federal Register notice addressing the use of 340B drugs at off-campus hospital outpatient locations that have not yet appeared on a filed Medicare cost report. These locations are known as “unregistered child sites.” In the notice, HRSA maintains that its prior policy allowing...
Continue Reading